Abstract
Apolipoprotein E (apoE) is associated with aging and some age-related diseases. The majority of apoE is produced by hepatocytes for the receptor-mediated uptake of lipoproteins. Here, the effects of age on the hepatic expression and distribution of apoE and its receptors were determined using immunofluorescence, Western blots, and quantitative PCR in rat liver tissue and isolated hepatocytes. The expression of apoE mRNA and protein was not influenced significantly by aging. Immunofluorescence studies in isolated hepatocytes showed that apoE was more likely to be co-localized with early endosomes, golgi, and microtubules in isolated old hepatocytes. The mRNA expression of the receptor involved in sequestration of apoE, heparan sulfate proteoglycan was reduced in old age, without any significant effect on the expression of either the low-density lipoprotein receptor or low density-lipoprotein receptor-related protein. Old age is associated with changes in hepatic apoE intracellular trafficking and heparan sulfate proteoglycan expression that might contribute to age-related disease.
Similar content being viewed by others
References
Ang LS, Cruz RP, Hendel A, Granville DJ (2008) Apolipoprotein E, an important player in longevity and age-related diseases. Exp Gerontol 43:615–622
Bose C, Bhuvaneswaran C, Udupa KB (2005) Age-related alteration in hepatic acyl-CoA: cholesterol acyltransferase and its relation to LDL receptor and MAPK. Mech Ageing Dev 126:740–751
Braeckman L, De Bacquer D, Rosseneu M, De Backer G (1998) The effect of age and lifestyle factors on plasma levels of apolipoprotein E. J Cardiovasc Risk 5:155–159
Cash AD, Aliev G, Siedlak SL, Nunomura A, Fujioka H, Zhu X, Raina AK, Vinters HV, Tabaton M, Johnson AB, Paula-Barbosa M, Avila J, Jones PK, Castellani RJ, Smith MA, Perry G (2003) Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation. Am J Pathol 162:1623–1627
Chou SC, Cheng B, Hornick TR, Kowal J, Abraham S (1996) Apolipoprotein E is increased in aged rat kidney. Biochem Mol Biol Int 38:847–854
Cooper AD (1997) Hepatic uptake of chylomicron remnants. J Lipid Res 38:2173–2192
Fazio S, Linton MF, Swift LL (2000) The cell biology and physiologic relevance of ApoE recycling. Trends Cardiovasc Med 10:23–30
Field PA, Gibbons GF (2000) Decreased hepatic expression of the low-density lipoprotein (LDL) receptor and LDL receptor related protein in aging rats is associated with delayed clearance of chylomicrons from the circulation. Metabolism 49:492–498
Galman C, Matasconi M, Persson L, Parini P, Angelin B, Rudling M (2007) Age-induced hypercholesterolemia in the rat relates to reduced elimination but not increased intestinal absorption of cholesterol. Am J Physiol Endocrinol Metab 293:E737–E742
Gee JR, Ding Q, Keller JN (2005) Modulation of apolipoprotein E and interleukin-1beta in the aging liver. Exp Gerontol 40:409–415
Heeren J, Grewal T, Jackle S, Beisiegel U (2001) Recycling of apolipoprotein E and lipoprotein lipase through endosomal compartments in vivo. J Biol Chem 276:42333–42338
Hilmer SN, Warren A, Cogger VC, Fraser R, McLean AJ, Sullivan D, Le Couteur DG (2004) The effect of aging on the immunohistochemistry of apolipoprotein E in the liver. Exp Gerontol 39:53–57
Hilmer SN, Cogger VC, Fraser R, McLean AJ, Sullivan D, Le Couteur DG (2005) Age-related changes in the hepatic sinusoidal endothelium impede lipoprotein transfer in the rat. Hepatology 42:1349–1354
Jellinger KA (2002) Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm 109:813–836
Ji ZS, Fazio S, Lee YL, Mahley RW (1994) Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans. J Biol Chem 269:2764–2772
Kockx M, Rye KA, Gaus K, Quinn CM, Wright J, Sloane T, Sviridov D, Fu Y, Sullivan D, Burnett JR, Rust S, Assmann G, Anantharamaiah GM, Palgunachari MN, Katz SL, Phillips MC, Dean RT, Jessup W, Kritharides L (2004) Apolipoprotein A-1-stimulated apolipoprotein E secretion from human macrophage is independent of cholesterol efflux. J Biol Chem 279:25966–25977
Kolovou GD, Anagnostopoulou KK (2007) Apolipoprotein E polymorphism, age and coronary heart disease. Ageing Res Rev 6:94–108
Le Couteur DG, Fraser R, Cogger VC, McLean AJ (2002) Hepatic pseudocapillarisation and atherosclerosis in ageing. Lancet 359:1612–1615
Le Couteur DG, Warren A, Cogger VC, Smedsrod B, Sorensen K, de Cabo R, Fraser R, McCuskey RS (2008) Old age and the hepatic sinusoid. Anat Rec 291:672–683
Liepa GU, Masoro EJ, Bertrand HA, Yu BP (1980) Food restriction as a modulator of age-related changes in serum lipids. Am J Physiol 238:E253–E257
Lingelbach LB, McDonald RB (2000) Description of the long-term lipogenic effects of dietary carbohydrates in male Fischer 344 rats. J Nutr 130:3077–3084
MacArthur JM, Bishop JR, Stanford KI, Wang L, Bensadoun A, Witztum JL, Esko JD (2007) Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members. J Clin Invest 117:153–164
Masoro EJ, Compton C, Yu BP, Bertrand H (1983) Temporal and compositional dietary restrictions modulate age-related changes in serum lipids. J Nutr 113:880–892
Pallottini V, Martini C, Cavallini G, Donati A, Bergamini E, Notarnicola M, Caruso MG, Trentalance A (2006) Modified HMG-CoA reductase and LDLr regulation is deeply involved in age-related hypercholesterolemia. J Cell Biochem 98:1044–1053
Parini P, Angelin B, Rudling M (1999) Cholesterol and lipoprotein metabolism in aging: reversal of hypercholesterolemia by growth hormone treatment in old rats. Arterioscler Thromb Vasc Biol 19:832–839
Pfaffl M (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acid Res 29:e45
Rao KM, Cohen HJ (1990) The role of the cytoskeleton in aging. Exp Gerontol 25:7–22
Sakurabayashi I, Saito Y, Kita T, Matsuzawa Y, Goto Y (2001) Reference intervals for serum apolipoproteins A-I, A-II, B, C-II, C-III, and E in healthy Japanese determined with a commercial immunoturbidimetric assay and effects of sex, age, smoking, drinking, and Lp(a) level. Clin Chim Acta 312:87–95
Siest G, Bertrand P, Herbeth B, Vincent-Viry M, Schiele F, Sass C, Visvikis S (2000) Apolipoprotein E polymorphisms and concentration in chronic diseases and drug responses. Clin Chem Lab Med 38:841–852
Smith JD (2002) Apolipoproteins and aging: emerging mechanisms. Ageing Res Rev 1:345–365
Swindell WR (2008) Comparative analysis of microarray data identifies common responses to caloric restriction among mouse tissues. Mech Ageing Dev 129:138–153
Taylor L, Jones AL, Schmucker DL (1992) Does aging affect liver microtubules? Proc Soc Exp Biol Med 199:441–445
Tollet-Egnell P, Flores-Morales A, Stahlberg N, Malek RL, Lee N, Norstedt G (2001) Gene expression profile of the aging process in rat liver: normalizing effects of growth hormone replacement. Mol Endocrinol 15:308–318
Walker RF, Ness GC, Zhao Z, Bercu BB (1994) Effects of stimulated growth hormone secretion on age-related changes in plasma cholesterol and hepatic low density lipoprotein messenger RNA concentrations. Mech Ageing Dev 75:215–226
Ward W, Richardson A (1991) Effect of age on liver protein synthesis and degradation. Hepatology 5:935–949
Yu KC, Cooper AD (2001) Postprandial lipoproteins and atherosclerosis. Frontiers Biosci 6:332–354
Zhu MY, Hasty AH, Harris C, Linton MF, Fazio S, Swift LL (2005) Physiological relevance of apolipoprotein E recycling: studies in primary mouse hepatocytes. Metabolism 54:1309–1315
Acknowledgments
We acknowledge funding from the Australian National Health and Medical Research Council and the Ageing and Alzheimer’s Research Foundation.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Sabaretnam, T., O’Reilly, J., Kritharides, L. et al. The effect of old age on apolipoprotein E and its receptors in rat liver. AGE 32, 69–77 (2010). https://doi.org/10.1007/s11357-009-9115-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11357-009-9115-2